Background: Alongside hazel, alder and birch pollen allergies, ash pollen allergy is a relevant cause of hay fever during spring in the European region. For some considerable time, ash pollen allergy was not routinely investigated and its clinical relevance may well have been underestimated, particularly since ash and birch tree pollination times are largely the same. Ash pollen extracts are not yet well standardized and diagnosis is therefore sometimes unreliable. Olive pollen, on the other hand, is strongly cross-reactive with ash pollen and is apparently better standardized.
Introduction
Pollinosis is the most common allergic disease in the European region and its prevalence is rising, currently reaching between 12% and 20% [1] . Alongside grass and herb pollen, tree pollen is also responsible for pollen allergies, primarily birch-like plants, with birch trees predominant among these, followed by alders and hazel, known triggers of spring pollinosis. However, various studies over recent years suggest that the relevance of ash pollen ought not to be underestimated. Studies carried out in France and Italy indicate that 18 %-34 % of allergies can be attributed to the ash tree [1, 2] . e common European ash (Fraxinus excelsior) Fraxinus excelsior) Fraxinus excelsior is a tall, wind-pollinated tree. Geographical distri-bution of the ash is restricted to mild central European zones, generally north of the Alps, and southern Scandinavia. erefore, most studies on ash pollen are carried out in Spain, France (Alsace), Switzerland and Austria. For a long time, ash pollen was not routinely investigated, due on the one hand to generally overlapping pollination periods, whilst on the other due to its cross-reactivity with trees in the Betulaceae family [3, 4] . e signi cance of ash pollen allergy was only recognized more recently. e reason for this lies in the only partial cross-reactivity with the Betulaceae family and evidence thatmost notably in Switzerland -the higher level of airborne ash pollen has led to increasing sensitization and a greater number of monovalent ash pollen all ergy su erers [6] .
From a phylogenetic perspective, ashes belong to the olive family (Oleaceae), which is widespread in the Mediterranean region, where it is of considerable importance. e common privet (Ligustrum vulgare), lilacs (Syringa spp.), forsythias (Forsythia spp.) and jasmine (Jasminus spp.) also belong to the Oleaceae family. A number of studies have demonstrated high cross-reactivity within this family [2] [7, 8] . However, there is only partial cross-reactivity between the Betulaceae and the Oleaceae plant families [9] . Ole e 1, a glycoprotein of 145-amino acids, is considered the chief marker allergen of Olea ceae, whereas Bet v 1 is considered the major allergen of Betulaceae [10] .
Several ash pollen allergens have been identi ed to date. e major allergen is Fra e 1, also a glycoprotein, which, due to its high sequential similarity with Ole e 1, displays extremely high cross-reactivity [11] . erefore, Ole e 1 is considered a marker allergen not only for the olive family, but also for ash pollen [7] .
Conventional pollen extracts contain mixtures of allergenic components as well as undesired products [12] . Determining these components precisely is complex and time-consuming due to their extremely low concentrations, the signi cant variability seen and the lack of standardization to date. Nevertheless, it has been possible in recent years to compile actual allergen pro les by means of proteomic investigations and to identify certain protein families, so-called major and minor allergens -thus also for the olive family (Oleaceae), including ashes, and the birch family.
In the case of ashes, it was revealed that, in addition to Fra e 1 as the major allergen, there is a multitude of other ash pollen allergens (so-called minor allergens, such as pro lin, Fra e 2, calmodulin, and Fra e 3). erefore, the protein families of pro lins and calmodulins are responsible for the cross-reactivity to pollen of other families. Moreover, there is evidence to suggest that bioactive lipids could also play a role in the context of the immune response [13] .
In addition to typical symptoms (rhinitis, conjunctivitis and possibly also asthma) and skin prick testing, serological detection of Ole e 1 (t224) has been considered adequate up to now due to its high sequence analogy with Fra e 1. However, clinical studies on the correlation between the Immuno-CAP® of Ole e 1 and that of ash pollen are lacking to date. is correlation is not banal, given that the composition of ash pollen has not yet been precisely identi ed and, in particular, due to the unclear and as yet unknown allergenic potential of these components. e aim of the present retrospective clinical study was to examine this postulate using a patient collective of pollinosis su erers from 2011/2012 in order to better record data on ash pollen su erers, not least in terms of immunotherapy.
Patients and methods
e study included 244 pollen allergy su erers living in the wider Zurich area that were seen in the allergy clinic at the Zurich university hospital in 2011 and, to a lesser extent, 2012. Inclusion criteria comprised typical symptoms (rhinitis, conjunctivitis and/or asthma), a positive skin prick test to ash or birch and Immuno CAP® detection of Ole e 1 (t224) and/or ash pollen (t25), as well as Bet v 1 (t215) and Bet v 2/v 4 (t221). Where lacking, CAP values for ash pollen were subsequently measured.
Speci c immunoglobulin E (IgE) was determined using the commercial ImmunoCAP® method ( ermo Fisher Phadia Diagnostics).
Results were interpreted according to recommendations set out by the manufacturer. e "cut-o " for speci c IgE was set at > 0.35 kU/l. In all, 61 subjects were excluded from the study, since insu cient serum was available for the subsequent detection of IgE to ash pollen. Ultimately, the de nitive patient collective comprised 183 subjects (n = 183).
Skin prick tests were carried out according to standard international criteria, using a positive (histamine) and a negative control (sodium chloride, NaCl). Commercial skin prick test extracts were used (ash pollen: Allergopharma Esche/Fraxinus excelsior No 116; birch pollen: Stallergenes Alyostal No 615). Evaluation was performed as follows: -Wheal size < 3 mm: negative -Wheal size < 5 mm: + positive -Wheal size to 7 mm: ++ positive -Wheal size > 7 mm: +++ positive -Plus pseudopods: ++++ positive Additional nasal provocation tests (NPT) using the commercial skin prick test solution for ash pollen were carried out in a subpopulation of nine patients.
ese were evaluated on the basis of sneezing (maximum of three points), rhinorrhea (maximum of three points) and reduced rhinomanometric ow (maximum of three points). NPTs were deemed positive from a score of four points.
Statistical calculations were performed by a professional statistician and the Spearman's Rank correlation coe cient was used for statistical analy sis. e investigation of data collected was approved by the ethics commission of the University of Zurich. All patients provided their written consent for the measurement and evaluation of data.
Results
Altogether, 183 subjects aged between 7 and 76 years (mean age, 35.8 years) were included in the study (75 females and 108 males). Tab. 1 shows the spectrum of sensitization in the study population. Tab. 2 lists the correlation coe cients between the various parameters compared, as well as possible signi cances. A clear correlation is seen primarily between ImmunoCAP for ash and Ole e 1, as well as Immuno-CAP for Ole e 1 and skin prick test with ash pollen extract. Fig. 1 shows the comparison of ImmunoCAP values for ash (t25) and Ole e 1 (t224). e relationship is signi cant and shows a clear correlation (correlation coe cient of 0.896). Fig. 2-4 show the relationships between skin prick tests and ImmunoCAP values. Fig. 2 shows the relationship between the ash skin prick test and ImmunoCAP values for Ole e 1 (t224), which is once again signi cant here with a correlation coe cient of 0.664. e relationship between the ash skin prick test and ash ImmunoCAP (t25) can be seen in Fig. 3 : although the relationship is much less marked here with a correlation coe cient of 0.604 than between ash skin prick test and ImmunoCAP Ole e 1, it is still signi cant. Nevertheless, it is valid to say that the skin prick test for ash pollen tends to correlate better with speci c IgE for Ole e 1 than with specific IgE to ash.
However, the correlation coe cient (0.604) is still greater than that between skin prick birch and ImmunoCAP Bet v 1 (t215), which is 0.566 (Fig. 4) .
All nine patients in whom an NPT was carried out showed sensitization to ash pollen in the skin prick test, but no sensitization to birch pollen. Immuno-CAP for Ole e 1 (t224) was > 0.7 kU/l (i.e., at least class 2) in six patients, whilst Immuno CAP for Ole e 1 was > 0.35 kU/l in the other three patients. NPT with ash pollen was positive in ve of six patients positive for IgE to Ole e 1; however, none of the three patients with an ImmunoCAP to Ole e 1 of < 0.35 kU/l tested positive on NPT with ash pollen.
e data in Tab. 2 permit analysis of the relationship between ImmunoCAP values for ash (t25) and Bet v 1 and Bet v 2. In this context, and as expected given the only partial cross-reactivity between Oleaceae and Betulaceae, no signi cant relationship could be seen between ImmunoCAP values for ash and Bet v 1 (correlation coe cient of 0.374) or ash and Bet v 2 (correlation coe cient of 0.478). us, the data suggest that the relationship between the ImmunoCAP for Ole e 1 and both the ImmunoCAP for ash and the ash skin prick test is relevant.
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Discussion
Due to their complex structure, natural pollen extracts in general and ash pollen in particular have been only partially standardized to date. ey differ not only in terms of their total protein volume, but also their major allergen content [14, 15, 16] . However, standardization is desirable and indeed necessary for the purposes of diagnosis and speci c immunotherapy. In Europe at least, there is a regulation whereby commercial batches need to be comparable based on the use of in-house reference preparation (IHRP); however, this regulation only applies within and not between companies. Hrabina et al. [4] established an IHRP of this kind for ash pollen, comprising a particular molecular characterization (including Fra e 1, Fra e 2, Fra e 3, a 15-kDa doublet and high-molecular weight proteins). In this way, it was possible to signi cantly reduce variability at least compared with non-standardized batches.
Several studies to date have created allergen proles of ash pollen allergy su erers [2, 5] . Using immunoblotting of ash pollen in 2010, Poncet [1] detected 200 spots, of which at least 100 proteins have allergenic characteristics. It has also been demonstrated that, due to a polymorphism, several isoforms -which can also be glycosylated to varying degrees -are formed from Fra e 1 [17] . Moreover, it was also possible to detect the other known panallergens, such as pro lins (Fra e 2) and calciumbinding proteins (Fra e 3) , that are mainly responsible for cross-reactivity to other trees and grasses.
e results presented here reveal that Ole e 1, and thus also the Fra e 1 allergen largely identical in se- quence, are of the utmost relevance as major allergens. e minor allergens found in ash pollen (t25), such as pro lin (Fra e 2), calcium-binding protein (Fra e 3) and HMW proteins, appear to play a subordinate role, at least in terms of detecting sensitization. is is also true to a certain extent of the comparison between ImmunoCAP Ole e 1 and the ash pollen skin prick test, although here too a signi cant correlation was seen in our patient collective. NPT with ash pollen was only positive in those patients who tested positive for IgE to Ole e 1. is also supports the signi cant clinical relevance of the Ole e 1 allergen in ash pollen allergy su erers. us Poncet's results are con rmed. In the present study, of 114 pollinosis su erers -sensitized to ash, olive or privet -86 % demonstrated an IgE response to Fra e 1. Although this result was presumed and expected, it had not as yet been investigated and demonstrated in a collective of this size.
Based on the results of this study, the signi cance of Ole e 1 and ash (t25) becomes apparent on the one hand, while on the other there are also scant di erences in results, which could possibly be attributed to the relevance of panallergens or a lack of pollen standardization.
is will be illustrated in more detail using individual patients (Tab. ere is also an interesting case (patient no. 151) that nicely illustrates residual cross-reactivity between birch and ash: ash: 6.13 kU/l, Ole e 1: 0.16 kU/l, Bet v 1: >100 kU/l, Bet v 2/v 4: 0.21 kU/l; the skin prick test was positive for birch (+++) and negative for ash. Due to the high ImmunoCAP value for Bet v 1, there was residual cross-reactivity to ash, hence the false-positive CAP result for ash pollen.
Since Ole e 1 plays such a dominant role at least in the diagnosis of ash pollen allergy, olive pollen extracts with a proven high Ole e 1 content can also be used as an alternative for the treatment of ash pollen allergies. Although based on small collectives, recent studies also suggest that Ole e 1 as an allergen could on its own indeed be su cient to treat olive pollen allergy [11] .
us one can conclude that, on the basis of the available results, the determination of speci c IgE to Ole e 1 is as e ective at detecting patients with clinically relevant ash pollen allergy as the determination of IgE to ash pollen (t25). Table 3 Interesting individual cases 
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